(Q40004623)

16 September 2017

title

Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma (English)

1 reference

16 September 2017

1 reference

ChEBI release 2020-05-28

1 reference

Michelle D Williams

3

0 references

author name string

Chandrani Chattopadhyay

series ordinal

1

1 reference

16 September 2017

Adel K El-Naggar

series ordinal

2

1 reference

16 September 2017

Gary L Clayman

series ordinal

4

1 reference

16 September 2017

publication date

1 August 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

30

1 reference

16 September 2017

issue

8

1 reference

16 September 2017

page(s)

991-1000

1 reference

c-Met expression of thyroid tissue with special reference to papillary carcinoma

16 September 2017

cites work

1 reference

7 January 2021

Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma

1 reference

7 January 2021

c-Met expression in gastric cancer with liver metastasis

1 reference

7 January 2021

Inhibition of the met receptor in mesothelioma

1 reference

7 January 2021

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

1 reference

7 January 2021

Met receptor tyrosine kinase: enhanced signaling through adapter proteins

1 reference

7 January 2021

HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells

1 reference

7 January 2021

Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors

1 reference

7 January 2021

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

1 reference

7 January 2021

Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma

1 reference

7 January 2021

A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin

1 reference

7 January 2021

c-Met: structure, functions and potential for therapeutic inhibition

1 reference

7 January 2021

Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage

1 reference

7 January 2021

Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells

1 reference

7 January 2021

Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.20816

1 reference

release_cap3abbzyzdlxcalcaqgaipvhy

16 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cap3abbzyzdlxcalcaqgaipvhy

24 November 2022

mapped directly with Wikidata item

1 reference